FACTOR INTERACTION ANTAGONISTS VIII WITH A PROTEIN RELATED TO LOW DENSITY LIPOPROTEIN RECEPTOR.

摘要

Use of a Factor VIII binding antibody for the preparation of a pharmaceutical composition to decrease the degradation of Factor VIII and / or prolong the half-life of Factor VIII in a biological fluid, in which the Factor VIII binding antibody comprises the amino acid sequences SEQ ID No: 17 and 19 of the heavy and light chains of KM41 or the amino acid sequences SEQ ID No: 21 and 23 of the heavy and light chains of KM33.